Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9599 posts found.

ABPI

UK trade associations form new life sciences lobbying group

January 11, 2011 Research and Development, Sales and Marketing ABHI, ABPI, BIA, BIVDA, LifeSciencesUK, lobbying

Four industry trade associations including pharma body the ABPI have banded together to form a new lobbying group representing life …
News

Novartis challenges Roche with MabThera biosimilar

January 11, 2011 Research and Development Lonza MabThera, Novartis, Roche, Teva, biosimilar, rituximab

Novartis’ generics unit Sandoz has begun mid-stage trials of a biosimilar version of Roche’s blockbuster drug MabThera. The phase II …
News
Food and Drug Administration (FDA)

FDA launches online transparency initiative

January 11, 2011 Medical Communications, Research and Development, Sales and Marketing FDA, Joshua Sharfstein, transparency

The FDA has launched a new online resource to increase the transparency of its processes and help save companies time …
News

Sanofi’s Genzyme takeover bid focuses on Campath

January 10, 2011 Research and Development, Sales and Marketing Genzyme, Sanofi, Sanofi-Aventis, biotech acquisition

Sanofi-Aventis and Genzyme have come back to the negotiation table to discuss the potential of Genzyme’s multiple sclerosis drug Campath. …
News
GSK's UK headquarters

GSK signs £64m autoimmune antibody deal

January 7, 2011 Research and Development GSK, GlaxoSmithKline, ImmuTune IMP731, Immutep, autoimmune diseases

GlaxoSmithKline has signed a worldwide licence agreement for a novel antibody designed to treat autoimmune diseases.The company will pay up …
News

Sanofi workers strike in France

January 7, 2011 Research and Development, Sales and Marketing Sanofi, Sanofi-Aventis, strikes, unions

Sanofi-Aventis workers have gone on strike in France as the company looks to cut jobs. Nine unions representing workers at …
News
Avastin (bevacizumab) packs

Study highlights Avastin heart failure risk

January 6, 2011 Research and Development, Sales and Marketing Roche, avastin, bevacizumab, breast cancer

A new study confirms that Roche’s Avastin is linked to a small but significant increased risk of heart failure in …
News

Biogen Idec appoints new head of R&D

January 6, 2011 Research and Development, Sales and Marketing Biogen IDEC, Douglas Williams, Steven Holtzman, appointment, research and development, sales and marketing

Biogen Idec has a new head of research and development, appointing Douglas Williams to oversee its global operations. The position …
Appointment

Merck KGaA opens outsourcing centre in India

January 5, 2011 Research and Development Application and Technology Centre, India, Merck KGaA, Merck Millipore, Millipore, outsourcing

Merck KGaA has opened a new technology centre near Mumbai in India that will offer a range of research services …
News

Contract research news in brief

January 5, 2011 Research and Development Accel Synthesis, Almac, Bioanalytical Systems, Caliper Life Sciences, Cambridge Research & Instrumentation, Critical Path Services, Pharmasset, ReSearch Pharmaceutical Services, ResourcingPoint, Warburg Pincus

Private equity firm Warburg Pincus buys RPS for $227 million, plus updates from BASi, Almac, Caliper, and Critical Path Services/Accel …
News

medeConnect Healthcare Insight appoints new managing director

January 5, 2011 Research and Development Doctors.net.uk, market research, medeconnect, medical professionals, qualitative, research

 
Appointment

EDC is Now – The Changing

January 5, 2011 Research and Development

Clinical research is rapidly moving toward the electronic environment as more  han half of all studies are conducted utilizing EDC, …
Feature
Thought Leadership

GSK’s Dr Anne Phillips moves to Novo Nordisk

January 4, 2011 Research and Development, Sales and Marketing Dr Anne Phillips, Novo Nordisk, apppointment, research and development, sales and marketing

Novo Nordisk has appointed Dr Anne Phillips as vice president for clinical, medical and regulatory affairs for North America. She …
Appointment

Achieve More in Phase I Studies

January 4, 2011 Research and Development

Some individuals believe not much has changed in Phase 1 dose escalation studies. A recent review1 that looked at 105 …
Feature
Thought Leadership
Novartis Holly Springs

Novartis adds R&D unit to new vaccines plant

December 31, 2010 Manufacturing and Production, Research and Development Novartis, pharma manufacturing, vaccines

Swiss drugmaker Novartis is planning to spend $36 million to set up an R&D laboratory on the site of its …
News
The Gateway to Local Adoption Series

Latest content

Siemens Healthineers opens 10m euro R&D centre for laboratory equipment in Ireland

February 19, 2026

Everdrone announces new board of directors to drive expansion

February 19, 2026

Regeneron announces presentations of new data on Eylea HD for retinal disease

February 18, 2026

Indegene completes acquisition of Cake Health

February 18, 2026

Gedeon Richter UK acquires rights to schizophrenia treatment Reagila from Recordati Pharmaceuticals

February 17, 2026